Benign neoplasm: Sigmoid colon

CD2_BENIGN_SIGMOID_COLON_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.5& Hospital discharge: ICD-8 — 21136 Cause of death: ICD-10 — D12.5& Cause of death: ICD-8 — 21136 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum coli sigmoidei

NAME	CD2_BENIGN_SIGMOID_COLON_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D125
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21136
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D125
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21136
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Sigmoid colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Sigmoid colon

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7270	3486	3784
Unadjusted period prevalence (%)	1.44	1.19	1.67
Median age at first event (years)	65.76	64.63	66.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6328: Matched controls
63289

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

4503599627370496.0

323.0

6269

107

UJF32

NOMESCO Finland

Coloscopy

14.2

323.0

4577

9827

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

19.2

323.0

800

473

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

23.6

323.0

639

300

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

15.9

323.0

1110

837

C61

ICD-10 Finland

Malignant neoplasm of prostate

293.5

323.0

512

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

473

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

8.7

323.0

1090

1482

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

24.0

323.0

583

266

UJF30

NOMESCO Finland

Ileoscopy through colon

6.4

323.0

1437

2790

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

5.2

323.0

2577

7340

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

16.4

323.0

925

653

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

5077.0

323.0

481

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

323.0

2854

12180

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

30.1

323.0

2325

1198

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

8.8

323.0

1461

2091

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

12.9

318.7

589

500

JN4BD

NOMESCO Finland

Extensive body CT

6.7

304.0

836

1402

PJA12

NOMESCO Finland

Sentinel node biopsy

373.8

287.7

288

115

Kela drug reimbursment

Breast cancer

+∞

283.4

270

H02AB02

ATC

dexamethasone; systemic

19.7

281.5

436

236

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

65.8

279.3

325

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

277.1

264

116

Kela drug reimbursment

Prostate cancer

+∞

272.8

260

L01BC06

ATC

capecitabine; oral

+∞

222.1

212

A04AA02

ATC

granisetron; systemic, transdermal

181.8

218.5

228

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

79.7

216.3

245

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

211.6

202

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

203.2

194

JN4AD

NOMESCO Finland

Body CT examination

6.4

197.3

555

938

WF002

NOMESCO Finland

Radical radiotherapy

67.9

192.6

223

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

187.4

179

A03FA01

ATC

metoclopramide; systemic, rectal

3.2

182.5

1081

3773

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

182.1

174

A02BC02

ATC

pantoprazole; systemic

2.2

177.8

4316

31393

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

176.8

169

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

174.0

3103

19674

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

168.4

161

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1725.2

167.3

162

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

165.6

2358

13447

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

279.7

160.3

163

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

1624.0

158.9

154

L02BG04

ATC

letrozole; oral

45.1

155.7

193

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

16.0

155.5

259

168

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.4

149.2

818

2668

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

146.3

868

2995

B01AB05

ATC

enoxaparin; parenteral

2.2

143.9

2056

11561

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

143.4

1812

9638

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

141.1

135

N02BE01

ATC

paracetamol; systemic, rectal

2.3

134.7

5458

46011

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

134.4

1851

10180

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

132.5

963

3791

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

131.3

1686

8967

WX302

NOMESCO Finland

Thoracal epidural anesthesy

6.9

130.2

342

521

L02AE02

ATC

leuprorelin; implant, parenteral

23.3

128.9

188

HAB40

NOMESCO Finland

Wedge excision of mammary gland

23.9

128.6

186

HAC20

NOMESCO Finland

Total mastectomy

193.9

128.1

133

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

125.4

120

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.6

123.2

453

1032

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

12.7

120.9

222

181

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

119.1

114

Y77

ICPC

Malignant neoplasm prostate

142.7

118.5

126

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

297.2

114.4

116

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

105.4

113.4

124

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.5

112.5

584

1807

L02BA01

ATC

tamoxifen; oral

122.2

111.4

120

L03AA13

ATC

pegfilgrastim; parenteral

225.8

107.9

111

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

278.2

107.2

109

L02BB03

ATC

bicalutamide; oral

536.7

107.0

106

WF003

NOMESCO Finland

Adjuvant radiotherapy

128.9

106.3

114

WF049

NOMESCO Finland

Radiotherapy of metastasis

275.5

106.2

108

ZX090

NOMESCO Finland

Other technic of radiotherapy

105.5

104.3

114

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

102.6

620

2137

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

510.8

101.8

101

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

1003.9

101.4

XX3DW

NOMESCO Finland

Time consuming IT work

3.8

100.7

462

1289

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

98.9

828

3499

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

98.5

876

3825

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

490.1

97.7

JFA42

NOMESCO Finland

Endoscopic injection in colon

28.5

97.6

134

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.6

96.2

476

1412

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

479.8

95.6

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

28.4

95.4

131

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

94.4

1484

8402

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

50.4

94.1

114

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

469.4

93.5

P01AB01

ATC

metronidazole; oral, rectal

1.8

93.1

2383

16005

JFB30

NOMESCO Finland

Right hemicolectomy

18.7

92.9

145

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

91.9

N02AX02

ATC

tramadol; systemic, rectal

1.7

91.8

2712

19024

S18

ICPC

Laceration/cut

1.7

89.8

2643

18477

UJH02

NOMESCO Finland

Anoscopy

3.8

89.2

408

1133

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

49.9

89.1

108

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

65.3

88.8

103

A04AA01

ATC

ondansetron; systemic, rectal

5.8

88.4

263

470

WX002

NOMESCO Finland

Sedation and analgesia

2.0

87.8

1385

7814

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

87.7

J01DB01

ATC

cefalexin; oral

1.8

87.6

4925

41644

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.0

86.7

249

426

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

86.6

JN4CD

NOMESCO Finland

Very extensive body CT

6.5

86.3

234

371

HA1AA

NOMESCO Finland

X-ray mammography

5.0

85.2

287

593

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

82.9

1982

12899

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

82.1

666

2748

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.1

80.8

229

385

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

27.1

80.6

112

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.2

80.6

913

4461

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

787.8

79.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

77.2

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

77.2

K92.1

ICD-10 Finland

Melaena

3.1

77.0

455

1533

XKD00

NOMESCO Finland

Uroflowmetry

2.0

76.4

1072

5735

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

75.1

UKC02

NOMESCO Finland

Cystoscopy

2.0

74.2

1083

5881

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

74.1

561

2218

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

74.1

C50.99

ICD-10 Finland

Breast, unspecified

371.5

73.8

Z51.5

ICD-10 Finland

Palliative care

4.8

73.7

256

546

K63.5

ICD-10 Finland

Polyp of colon

7.4

73.2

181

252

A02BC05

ATC

esomeprazole; systemic

1.7

73.1

2525

18138

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

73.0

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

73.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

73.0

1098

6030

H02AB06

ATC

prednisolone; systemic

1.6

72.1

2893

21604

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

29.2

72.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

71.7

1145

6427

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

71.5

780

3733

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

71.4

519

2002

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

17.3

71.2

114

ZX120

NOMESCO Finland

Intravenous

2.7

70.6

537

2127

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

70.3

252

556

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

109.8

70.0

N02AA05

ATC

oxycodone; systemic

2.2

70.0

803

3930

J01MA02

ATC

ciprofloxacin; systemic

1.6

69.9

2393

17079

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

235.8

68.4

C50

ICD-10 Finland

Malignant neoplasm of breast

235.8

68.4

R4110

NOMESCO Finland

Physiotherapy

1.8

67.9

1566

9946

KCD02

NOMESCO Finland

Transurethral resection of bladder

15.2

67.9

114

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.2

67.8

377

1217

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

7.8

67.8

161

211

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

66.8

WX110

NOMESCO Finland

Local anesthesy

1.6

66.7

3799

30752

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

65.7

A02BC03

ATC

lansoprazole; oral

1.7

65.2

1931

13178

A04AA55

ATC

palonosetron, combinations; systemic

+∞

64.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

19.5

64.0

ZXC96

NOMESCO Finland

Robot assisted procedure

11.7

63.7

120

104

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

63.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

63.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.5

63.5

540

2272

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

12.6

63.0

115

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

62.8

1245

7501

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

62.6

SPAT1153

SPAT

Removal of sutures

1.6

61.6

1954

13542

J01MA12

ATC

levofloxacin; systemic

1.8

60.6

1142

6754

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

60.5

WZC30

NOMESCO Finland

Teaching

2.2

60.2

652

3094

WF004

NOMESCO Finland

Palliative radiotherapy

129.2

59.9

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

59.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

59.4

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

58.1

58.6

ZX070

NOMESCO Finland

Intensity modified radiotherapy

125.1

57.9

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

57.4

C05AA08

ATC

fluocortolone; rectal, topical

1.9

57.1

942

5308

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

198.4

57.1

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

56.3

R06.0

ICD-10 Finland

Dyspnoea

1.7

56.3

1608

10774

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

289.2

56.3

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

14.8

56.1

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

55.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

54.3

1016

5972

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

54.3

618

2994

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

278.5

54.2

B01AB10

ATC

tinzaparin; parenteral

2.9

53.3

345

1234

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

522.0

52.5

A04AD12

ATC

aprepitant; systemic

511.8

51.5

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

51.1

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

51.1

L02BG03

ATC

anastrozole; oral

82.2

50.9

JFB46

NOMESCO Finland

Resection of sigmoid colon

7.2

50.9

127

180

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

55.0

50.6

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

64.9

50.2

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

257.3

50.1

WX402

NOMESCO Finland

General anaesthesia

1.9

49.5

770

4227

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.9

49.4

814

4564

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

14.7

49.0

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

49.0

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.2

48.9

268

855

C03CA01

ATC

furosemide; systemic

1.5

48.5

1923

13902

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

48.5

1314

8617

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

15.2

48.4

L03AA02

ATC

filgrastim; parenteral

24.0

48.4

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

38.5

48.1

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

12.4

47.7

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

47.4

578

2876

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

471.1

47.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

241.6

47.0

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

21.8

47.0

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

46.9

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

46.8

474

2171

X76

ICPC

Malignant neoplasm breast female

102.8

46.8

R03AC02

ATC

salbutamol; inhalant

1.5

46.8

2962

23670

WW500

NOMESCO Finland

Blood transfusion

4.1

46.6

188

466

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

46.6

330

1245

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.3

46.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

46.4

611

3141

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

460.9

46.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

46.2

2689

21095

R03BB04

ATC

tiotropium bromide; inhalant

1.9

46.1

721

3958

N03AX16

ATC

pregabalin; oral

1.6

45.6

1386

9349

UJF34

NOMESCO Finland

Left colonoscopy

9.2

45.6

107

A06AD11

ATC

lactulose; oral

1.8

45.5

904

5393

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

231.5

45.0

AA1AD

NOMESCO Finland

CT of head and brain

1.6

44.9

1570

10969

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

44.8

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

44.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.5

44.7

222

657

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.5

44.5

221

654

J01AA02

ATC

doxycycline; systemic

1.5

44.4

4663

41128

N05CF01

ATC

zopiclone; oral

1.5

44.3

1926

14151

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

43.8

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

43.8

J01CA04

ATC

amoxicillin; systemic

1.5

43.7

4541

39870

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.4

43.7

224

680

ZZR00

NOMESCO Finland

Flap of skin

8.3

43.3

120

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

43.2

602

3162

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.5

43.2

214

633

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

43.1

2058

15412

D01

ICPC

Abdominal pain/cramps general

2.0

43.0

579

2998

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

42.4

1050

6682

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

42.2

315

1225

G04CA02

ATC

tamsulosin; oral

1.6

41.8

1512

10616

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.3

41.8

223

698

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

41.7

UJG02

NOMESCO Finland

Proctoscopy

4.3

41.5

161

385

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

41.4

2169

16533

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

41.3

2623

20785

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

40.7

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

40.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

40.7

K62.7

ICD-10 Finland

Radiation proctitis

+∞

40.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

40.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

40.5

1435

10015

N06AX11

ATC

mirtazapine; oral

1.5

40.4

1770

12967

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

40.4

235

783

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

8.4

40.3

108

D75

ICPC

Malignant neoplasm colon/rectum

59.1

40.2

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.8

39.9

277

1034

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

39.9

3837

32810

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

39.9

870

5327

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

140.8

39.8

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

39.6

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

39.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

39.6

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.1

39.1

126

249

JG1BG

NOMESCO Finland

MRI of rectum

36.0

39.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

38.9

2278

17693

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

38.9

343

1465

K62.1

ICD-10 Finland

Rectal polyp

5.7

38.8

114

202

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

201.1

38.8

128

Kela drug reimbursment

Cancers of female genital organs

201.1

38.8

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

38.6

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

38.6

UJF92

NOMESCO Finland

Capsular endoscopy

3.9

38.4

165

434

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.8

38.1

115

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

37.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

37.1

898

5658

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

369.4

37.0

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

36.7

242

874

ZXA00

NOMESCO Finland

Right side

1.5

36.6

1603

11696

C07AB07

ATC

bisoprolol; oral

1.4

36.6

3071

25423

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

36.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

36.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

36.5

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

36.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.0

36.3

149

377

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

36.1

295

1210

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

36.0

833

5177

J01DA01

ATC

[U] cefalexin; systemic

1.4

35.8

3548

30193

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

35.4

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

9.8

35.3

ZXA05

NOMESCO Finland

Left side

1.5

35.2

1501

10870

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

35.1

513

2735

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

35.1

1684

12503

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

35.1

247

931

SPAT1104

SPAT

Monitoring of emergency patient

2.1

35.0

440

2211

ZX080

NOMESCO Finland

Image guided radiotherapy

67.0

35.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

34.9

996

6556

JFB43

NOMESCO Finland

Left hemicolectomy

15.0

34.8

C90.0

ICD-10 Finland

Multiple myeloma

124.0

34.7

J01FA06

ATC

roxithromycin; oral

1.4

34.5

2277

17973

A02BA02

ATC

ranitidine; systemic

1.5

34.5

1227

8521

A02BC01

ATC

omeprazole; systemic

1.5

34.5

1646

12202

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

34.4

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

34.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

34.4

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

34.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

34.3

343

1556

N05BA04

ATC

oxazepam; oral

1.5

34.2

1341

9520

SPAT1263

SPAT

Sampling

1.4

34.0

2422

19374

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

338.9

33.9

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

10.1

33.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

33.9

416

2069

D16

ICPC

Rectal bleeding

3.4

33.8

167

494

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.3

33.7

337

1532

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

120.6

33.7

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.9

33.6

113

235

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

33.4

578

3275

L02BG06

ATC

exemestane; oral

+∞

33.3

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

33.3

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

38.4

33.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

33.3

142

372

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

33.3

661

3916

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

63.6

33.0

R31

ICD-10 Finland

Unspecified haematuria

1.8

33.0

582

3318

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

33.0

576

3272

TJF80

NOMESCO Finland

Ostomy education

13.0

32.8

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

24.4

32.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

32.4

643

3806

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

32.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

32.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

32.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

32.3

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

9.6

32.2

R50.9

ICD-10 Finland

Fever, unspecified

1.7

32.1

662

3968

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.9

31.9

196

678

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

318.5

31.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

318.5

31.9

H02AB07

ATC

prednisone; oral

1.6

31.8

821

5250

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.7

31.7

222

834

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

113.9

31.7

J02AC01

ATC

fluconazole; systemic

1.4

31.6

1888

14573

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

31.3

368

1797

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

31.3

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

31.3

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

53.1

31.3

E0000UV

ATC

1.4

31.2

2047

16066

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.5

30.9

125

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.4

30.8

265

1118

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

30.7

251

1028

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

30.7

5062

46429

M54.5

ICD-10 Finland

Low back pain

1.4

30.6

1713

13045

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

30.2

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

30.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

30.1

105

228

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

155.7

29.7

SPAT1301

SPAT

No procedures

1.4

29.6

1847

14330

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

29.5

1010

6924

M79.6

ICD-10 Finland

Pain in limb

1.4

29.5

1982

15581

R53

ICD-10 Finland

Malaise and fatigue

1.5

29.3

1113

7809

L02BX02

ATC

degarelix; parenteral

+∞

29.2

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

29.2

R60.0

ICD-10 Finland

Localized oedema

1.7

28.9

657

4050

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

293.1

28.8

TQW20

NOMESCO Finland

Tatoe

103.8

28.6

N06AB04

ATC

citalopram; systemic

1.5

28.6

1162

8275

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

28.5

423

2265

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.3

28.5

262

1143

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

29.4

28.5

D06

ICPC

Abdominal pain localized other

1.9

28.4

416

2217

C08CA01

ATC

amlodipine; oral

1.4

28.4

2267

18323

ICD-10 Finland

2.9

28.3

176

615

S77

ICPC

Malignant neoplasm of skin

20.1

28.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

28.1

A79

ICPC

Malignancy NOS

31.0

28.1

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

28.1

303

1427

JFF23

NOMESCO Finland

Transversostomy

11.6

28.0

G04BE03

ATC

sildenafil; oral

8.0

28.0

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.9

28.0

172

594

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

28.0

285

1307

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

27.9

211

829

L03AA14

ATC

lipegfilgrastim; parenteral

282.6

27.8

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

42.7

27.7

R01AD09

ATC

mometasone; nasal

1.4

27.4

2254

18272

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

27.4

237

1002

TKE10

NOMESCO Finland

Puncture of prostate

47.3

27.4

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

47.3

27.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

35.2

27.4

JG1CG

NOMESCO Finland

Extensive MRI of rectum

23.1

27.3

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.5

27.2

128

366

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

27.1

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

27.1

G47.3

ICD-10 Finland

Sleep apnoea

1.5

27.1

1238

9023

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

14.6

26.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

272.1

26.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.3

26.7

138

425

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.4

26.6

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

26.5

841

5653

N05CF02

ATC

zolpidem; oral

1.5

26.4

886

6030

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

26.0

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

26.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

25.9

555

3356

WX892

NOMESCO Finland

Monitored bed care

1.8

25.9

432

2412

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.4

25.9

223

940

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

25.7

367

1938

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

25.5

1464

11127

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

25.5

2321

19054

L57.0

ICD-10 Finland

Actinic keratosis

1.8

25.5

451

2568

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.8

25.4

172

633

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

25.4

1806

14251

D11

ICPC

Diarrhoea

1.8

25.3

497

2928

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

50.2

25.2

J01FF01

ATC

clindamycin; systemic

1.4

25.1

1461

11131

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

25.1

1345

10095

R4190

NOMESCO Finland

Nutritional therapy

3.3

25.0

131

407

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

25.0

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

25.0

J01MA14

ATC

moxifloxacin; systemic

1.8

25.0

471

2735

N06AX16

ATC

venlafaxine; oral

1.7

24.9

599

3741

SPAT1254

SPAT

Administration of medicine

1.5

24.9

812

5487

D18

ICPC

Change in faeces/bowel movements

3.1

24.8

138

449

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

3.0

24.7

149

511

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

251.0

24.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

24.7

799

5389

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

130.5

24.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

24.6

352

1861

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

43.0

24.5

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

24.5

659

4240

Z01.7

ICD-10 Finland

Laboratory examination

1.7

24.5

596

3736

M03BX02

ATC

tizanidine; oral

1.3

24.3

3276

28435

WX290

NOMESCO Finland

Other blockade of nerve

1.4

24.1

1941

15598

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

24.0

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

24.0

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

24.0

A07EC02

ATC

mesalazine; oral, rectal

2.1

23.9

292

1450

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.2

23.9

226

R03BA02

ATC

budesonide; inhalant

1.5

23.9

914

6402

KAC10

NOMESCO Finland

Total nephrectomy with capsule

20.7

23.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.7

23.8

163

607

A06AC51

ATC

ispaghula, combinations; systemic

2.0

23.6

296

1487

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

23.5

265

1269

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

23.4

2690

22773

A07AA02

ATC

nystatin; oral

1.9

23.4

344

1837

S21

ICPC

Skin texture symptom/complaint

1.6

23.3

644

4173

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

23.3

970

6910

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

46.8

23.3

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.4

23.3

130

Z31.5

ICD-10 Finland

Genetic counselling

2.8

23.2

156

574

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

23.1

428

2470

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.9

23.1

248

K02.1

ICD-10 Finland

Caries of dentine

1.3

23.1

2792

23790

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

23.0

211

921

K64.0

ICD-10 Finland

First degree haemorrhoids

3.8

23.0

259

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

23.0

291

1467

C187, 8211, 2

ICD-O-3

+∞

22.9

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

22.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

22.9

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

22.9

H02AB04

ATC

methylprednisolone; systemic

1.5

22.9

809

5562

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

22.9

330

1747

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.7

22.7

168

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

83.7

22.7

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

230.7

22.6

A08

ICPC

Swelling

2.2

22.6

249

1181

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.8

22.6

152

560

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

120.4

22.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

22.6

1061

7743

J01EA01

ATC

trimethoprim; systemic

1.4

22.5

1237

9297

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

22.4

3595

31798

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.8

22.4

145

520

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.4

22.4

128

JN6AD

NOMESCO Finland

CT of torso and neck

7.9

22.4

M25.5

ICD-10 Finland

Pain in joint

1.4

22.3

1454

11262

J20

ICD-10 Finland

Acute bronchitis

1.7

22.3

510

3139

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

22.1

123

401

R51.80

ICD-10 Finland

Headache

1.6

22.0

669

4436

JAH01

NOMESCO Finland

Laparoscopy

2.4

22.0

183

760

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

21.9

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

21.9

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

21.9

R11

ICD-10 Finland

Nausea and vomiting

1.8

21.8

375

2115

R05

ICD-10 Finland

Cough

1.4

21.8

1030

7517

ZX112

NOMESCO Finland

Subcutaneous

5.6

21.8

116

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

25.1

21.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

21.6

868

6132

N30.0

ICD-10 Finland

Acute cystitis

1.5

21.6

690

4633

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

21.5

833

5835

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

21.5

295

1534

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

21.5

403

2339

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

21.4

270

1356

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3024561) Albumin [Mass/volume] in Serum or Plasma

4066

24513

2.49

309.73

5.8

3.8

g/l

35.1

35.5

4.93

3854

22331

(3022145) Colonoscopy Study observation

2718

5720

6.99

307.65

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1655

3216

6.37

307.65

4.4

1.5

ug/l

29.3

7.5

0.60

1402

2439

(40768804) Tissue Pathology biopsy report

3687

18538

3.01

307.65

2.5

1.7

—

(4035726)

848

1700

5.51

307.65

1.4

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4664

28248

2.82

307.65

6.9

3.8

umol/l

11.4

12.0

2.06

4449

26372

(3044640) Blood type and Crossmatch panel - Blood

3026

16379

2.45

286.12

3.0

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6006

44515

3.01

283.53

9.6

5.5

u/l

79.8

76.0

8.65

5745

41061

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2466

12568

2.46

261.47

2.9

2.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4603

30852

2.34

254.92

10.1

6.3

e9/l

4.3

1.12

4035

26336

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3914

24842

2.25

242.48

4.6

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2696

15079

2.25

223.12

2.8

2.3

mg/l

3.4

2.9

11.98

2379

12755

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4054

26916

2.14

213.81

7.4

5.3

mmol/l

1.2

4.01

3700

23739

(40768797) Stomach Pathology biopsy report

1708

8223

2.41

197.17

1.3

1.2

—

(3002256) Pathology report gross observation

1150

4579

2.80

196.82

1.4

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3016

18406

2.09

192.67

3.0

2.3

u/l

57.7

59.8

0.92

2802

16772

(3031040) Bacteria [#/volume] in Urine by Automated count

5143

38402

2.16

187.23

5.7

4.4

e6/l

344.6

2013.7

4.99

589

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1088

4330

2.78

185.69

2.5

2.0

g/l

0.2

7.40

1027

3912

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4258

29810

2.03

182.48

8.5

5.8

mmol/l

1.2

9.01

3768

24921

(3006315) Basophils [#/volume] in Blood

4085

28205

2.02

181.74

6.8

5.4

e9/l

0.0

1.34

3543

24051

(3001604) Monocytes [#/volume] in Blood

4063

28020

2.02

181.12

6.8

5.4

e9/l

0.6

0.64

3523

23865

(3013115) Eosinophils [#/volume] in Blood

4178

29153

2.02

179.50

7.0

5.6

e9/l

0.2

2.34

3660

25227

(3019198) Lymphocytes [#/volume] in Blood

4135

28779

2.01

178.58

6.8

5.5

e9/l

1.9

1.8

1.30

3614

24979

(3033658) Prothrombin time (PT) actual/Normal

2390

13691

2.11

177.51

5.1

3.5

88.1

86.7

1.76

2342

13328

(40758558) Short blood count panel - Blood

2271

12911

2.10

170.86

7.4

4.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2940

18438

2.00

167.96

3.7

2.1

mmol/l

2.4

0.02

2529

15280

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3911

27090

1.96

166.65

2.3

2.0

pmol/l

94.4

94.8

0.20

2235

13759

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3459

23010

1.96

165.81

3.7

2.8

ug/l

126.4

136.0

1.31

3229

20933

(3048689) Calprotectin [Mass/mass] in Stool

1330

6143

2.43

165.46

2.2

ug/g

139.8

145.9

0.29

1068

4767

(3013826) Glucose [Moles/volume] in Serum or Plasma

4745

35171

2.01

165.15

6.0

4.4

mmol/l

6.9

6.8

0.43

4499

32861

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

458

1159

4.15

161.42

3.4

1.9

u/ml

522.7

81.1

0.89

393

935

(3013707) Erythrocyte sedimentation rate by Westergren method

5606

44328

2.16

160.75

5.1

4.2

mm/h

14.3

12.5

13.79

5200

40696

(3023368) Bacteria identified in Blood by Culture

2577

15758

1.98

155.38

4.8

3.9

—

(3032080) INR in Blood by Coagulation assay

3629

24901

1.91

154.85

10.8

10.3

inr

1.3

0.44

727

6885

(3037467) Urinalysis macro (dipstick) panel - Urine

5223

40649

2.01

150.28

5.4

4.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1735

9360

2.12

146.37

3.1

2.6

umol/l

11.9

12.9

6.74

1631

8539

(3014576) Chloride [Moles/volume] in Serum or Plasma

1438

7321

2.20

140.00

7.9

6.6

mmol/l

104.5

104.3

0.98

1424

7146

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1606

8594

2.12

137.30

3.1

2.6

g/l

2.3

1.65

1515

7851

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1526

8019

2.14

136.73

3.2

2.7

20.5

22.5

6.66

1369

6684

(42870588) Differential panel, method unspecified - Blood

2892

18995

1.87

135.89

6.6

5.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

917

3917

2.53

133.14

1.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1202

5815

2.28

131.86

4.1

2.7

u/l

235.2

241.1

0.65

1146

5376

(3027945) Reticulocytes/100 erythrocytes in Blood

1343

6829

2.19

130.22

2.5

2.1

1.8

2.28

1217

5929

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6671

58292

2.76

127.58

23.0

13.4

mg/l

26.4

24.0

7.05

5729

45730

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1035

4770

2.36

126.81

2.6

2.2

u/l

31.6

49.5

1.08

894

4041

(3019069) Monocytes/100 leukocytes in Blood

3640

26139

1.79

123.66

7.4

5.9

8.8

0.42

3417

24098

(3018095) Leukocytes [#/volume] in Urine

3015

20486

1.81

123.53

4.4

3.5

e6/l

77.5

109.2

1.50

2181

14405

(3014007) Fractional oxyhemoglobin in Arterial blood

849

3618

2.52

123.40

8.6

9.1

93.6

93.5

0.15

849

3603

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1756

10046

1.99

123.15

3.1

2.6

e6/l

1.2

0.08

1091

5810

(3006504) Eosinophils/100 leukocytes in Blood

3621

25995

1.78

122.84

7.0

5.6

2.8

3.0

3.61

3388

23854

(3011397) Hemoglobin [Presence] in Urine by Test strip

2278

14221

1.88

122.78

4.7

3.7

—

(3000991) Gas panel - Venous blood

1022

4760

2.33

121.91

8.7

8.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1803

10516

1.95

118.93

3.5

2.2

mmol/l

2.5

2.14

1591

9005

(3007164) IgA [Mass/volume] in Serum or Plasma

1700

9732

1.97

118.35

1.5

1.3

g/l

2.6

0.04

941

5491

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1176

5873

2.20

118.32

2.9

2.2

umol/l

8.5

8.0

0.34

1046

5048

(3018010) Neutrophils/100 leukocytes in Blood

3647

26439

1.76

117.75

6.9

5.6

58.1

57.8

0.87

3396

24358

(3002030) Lymphocytes/100 leukocytes in Blood

3676

26722

1.76

117.44

7.2

5.8

26.4

27.2

4.23

3412

24479

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1534

8543

2.01

115.17

3.7

2.5

mmol/l

0.8

5.31

1446

7801

(3030467) Casts [#/volume] in Urine by Automated count

2483

16171

1.81

115.14

3.7

2.9

e6/l

0.4

0.5

0.87

1911

12025

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1919

11551

1.90

114.41

1.3

1.2

u/ml

1.5

1.9

0.71

451

3038

(3022096) Basophils/100 leukocytes in Blood

3495

25247

1.74

112.36

7.1

5.7

0.7

1.00

3266

23194

(36304419) Bacteria [Presence] in Urine

2385

15502

1.80

110.27

3.7

2.9

—

(3023520) Reticulocytes [#/volume] in Blood

1046

5137

2.21

109.07

2.6

2.2

e9/l

70.4

68.7

0.86

825

3915

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

678

2777

2.59

106.40

1.6

g/l

1.6

1.5

1.50

591

2362

(3003396) Base excess in Arterial blood by calculation

1279

6852

2.05

106.06

7.2

7.0

mmol/l

0.7

1.3

4.60

1016

5309

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1276

6894

2.03

103.10

7.3

7.0

kpa

5.1

1.23

1228

6560

(3014111) Lactate [Moles/volume] in Serum or Plasma

1025

5100

2.18

103.04

7.5

6.8

mmol/l

1.3

1.4

2.41

996

4914

(3027801) Oxygen [Partial pressure] in Arterial blood

1275

6888

2.03

103.04

7.3

7.0

kpa

12.1

11.6

2.17

1220

6543

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1344

7435

1.99

101.43

7.2

5.5

mmol/l

1.1

1.0

1.43

1263

6815

(3042936) Bacteria identified in Isolate by Culture

1400

7913

1.95

99.02

2.3

2.1

—

(3002582) Erythrocytes [#/volume] in Urine

2567

17570

1.71

95.84

3.9

3.0

e6/l

103.0

97.1

0.05

2009

13340

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1540

9091

1.88

95.01

3.4

2.7

e6/l

2.6

2.5

0.19

887

4897

(3016502) Oxygen saturation in Arterial blood

1158

6208

2.03

94.92

7.4

7.3

95.4

95.2

0.77

1129

5963

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1068

5584

2.07

93.67

7.9

7.8

g/l

119.6

122.7

5.30

1042

5371

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

759

3468

2.33

93.32

2.6

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4502

35999

1.66

89.69

4.1

3.0

u/l

58.5

48.3

8.89

4166

32857

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2523

17476

1.68

88.32

3.5

2.6

u/l

32.4

34.6

0.95

2365

16400

(3018418) pH of Serum or Plasma

2501

17297

1.68

87.99

5.2

3.3

7.4

0.51

310

3065

(3020779) Urea [Moles/volume] in Serum or Plasma

1004

5252

2.06

87.52

9.1

7.1

mmol/l

10.6

10.9

0.70

956

4952

(3035350) Ketones [Presence] in Urine by Test strip

3769

29000

1.62

86.06

4.6

3.7

estimate

0.0

0.50

437

4952

(3009261) Glucose [Presence] in Urine by Test strip

3804

29342

1.62

85.93

4.7

3.8

estimate

0.0

0.19

436

4849

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2813

20178

1.64

85.09

3.5

3.1

ng/l

1481.9

1478.6

0.01

2496

17376

(3021960) Folate [Moles/volume] in Serum or Plasma

2260

15326

1.69

85.01

1.7

1.5

nmol/l

21.0

20.4

0.67

1985

12863

(3007853) Bacteria identified in Skin by Aerobe culture

1182

6646

1.93

83.52

1.9

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

1882

12213

1.73

82.88

2.8

2.5

e6/l

4.2

4.9

2.68

1626

10546

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1570

9674

1.79

82.83

2.1

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

656

2980

2.32

81.32

9.4

9.2

mmol/l

24.1

24.5

2.02

614

2726

(3021601) Nitrite [Presence] in Urine by Test strip

3744

29003

1.60

81.20

6.1

5.0

estimate

0.0

0.80

455

5009

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5295

44743

1.68

79.36

4.4

3.9

pmol/l

15.0

14.9

0.91

4814

40131

(3019309) Folate [Moles/volume] in Red Blood Cells

1963

13025

1.69

79.02

1.8

nmol/l

1142.6

1158.9

0.29

1531

9743

(40761535) Cells panel - Urine sediment

993

5359

1.99

78.77

4.6

3.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

946

5045

2.01

77.55

2.5

1.6

g/l

66.2

66.8

1.37

862

4467

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1489

9196

1.78

77.27

2.3

2.0

30.0

0.05

1439

8903

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6159

54465

1.86

76.42

5.6

4.7

mu/l

2.3

2.1

0.28

5668

49176

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3287

24934

1.58

76.14

4.8

3.8

ng/l

38.2

84.6

2.73

2507

18121

(3019550) Sodium [Moles/volume] in Serum or Plasma

6776

62012

2.37

75.84

26.9

16.4

mmol/l

139.6

139.8

6.97

6684

60312

(3023103) Potassium [Moles/volume] in Serum or Plasma

6776

62155

2.33

72.94

27.1

16.5

mmol/l

4.0

0.72

6681

60364

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6229

55474

1.86

72.82

19.9

12.5

ml/min/173m2

75.5

76.0

0.86

5337

44754

(3014765) Yersinia sp identified in Stool by Organism specific culture

411

1581

2.70

72.54

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

412

1587

2.69

72.53

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

407

1570

2.69

71.43

1.3

1.2

—

(3026008) Bacteria identified in Urine by Culture

2492

17915

1.59

71.34

3.7

3.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

248

720

3.53

71.25

2.9

2.0

u/ml

147.5

408.4

0.58

227

647

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3201

24384

1.56

71.13

2.5

2.2

nmol/l

78.2

79.0

0.86

2847

21331

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

450

1861

2.51

68.45

2.9

3.2

u/ml

0.3

0.4

1.15

266

1097

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1854

12513

1.65

68.14

2.0

1.7

mg/l

1.2

0.12

1447

9608

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1015

5804

1.87

66.92

4.5

3.8

kpa

5.8

0.44

980

5646

(3002032) Base excess in Venous blood by calculation

1014

5798

1.87

66.86

4.5

3.8

mmol/l

1.7

1.9

1.02

844

4734

(3026493) Urate [Moles/volume] in Serum or Plasma

2307

16500

1.58

66.38

3.1

2.5

umol/l

4875.2

5685.5

0.38

1997

14000

(40768793) Breast Pathology biopsy report

148

312

4.82

65.50

1.3

1.2

—

(3026782) Osmolality of Urine

1688

11219

1.66

65.50

3.1

2.6

mosm/kgh2o

548.8

548.2

0.03

1388

9371

(40761511) CBC panel - Blood by Automated count

6612

60481

2.03

65.14

21.7

13.1

—

(3019150) Specific gravity of Urine by Refractometry

1927

13274

1.61

64.62

5.4

4.2

kg/l

1.0

0.23

310

2000

(3000570) Elastase.pancreatic [Mass/mass] in Stool

409

1673

2.53

63.60

1.5

1.4

ug/g

262.4

283.9

1.25

249

987

(3022217) INR in Platelet poor plasma by Coagulation assay

1422

9103

1.70

63.40

33.3

28.5

inr

1.5

1.4

0.63

153

1241

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6776

62695

2.19

62.29

14.8

9.4

u/l

25.8

25.7

0.06

6600

59838

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1339

8475

1.71

62.11

10.6

6.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

325

1211

2.76

60.92

1.5

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1109

6691

1.78

60.86

2.0

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

691

3584

2.03

60.48

1.9

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

842

4685

1.90

60.01

4.6

3.8

ng/l

98.3

94.9

0.45

745

3936

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1055

6305

1.79

59.71

2.7

2.4

ug/l

6.7

7.8

0.96

924

5468

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2686

20228

1.52

59.63

2.3

2.2

u/l

205.3

231.8

0.63

2518

18829

(3004716) Salmonella sp identified in Stool by Organism specific culture

488

2237

2.27

58.70

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1097

6695

1.75

57.58

2.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

794

4396

1.90

57.32

2.3

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

562

2760

2.12

56.87

4.3

4.1

mmol/l

24.1

24.2

0.22

499

2444

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

842

4769

1.87

56.61

2.5

2.4

ml/min/173m2

62.6

62.8

0.04

362

1849

(3020891) Body temperature

533

2576

2.15

56.19

5.5

4.9

—

(3013512) EKG study

2516

18895

1.51

55.56

4.8

4.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

842

4849

1.83

53.51

3.7

3.2

kpa

4.6

4.5

0.51

811

4697

(40768800) Prostate Pathology biopsy report

164

437

3.82

53.49

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

571

2900

2.05

52.72

1.4

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

129

292

4.48

52.36

3.4

1.6

nmol/l

8.2

4.5

0.94

123

280

(3017143) Hepatitis C virus Ab [Presence] in Serum

778

4419

1.85

51.59

1.7

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

610

3230

1.97

50.01

8.6

7.4

mmol/l

24.8

0.04

603

3192

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

632

3403

1.94

49.31

1.6

1.4

—

(4010399)

802

4675

1.80

48.73

1.5

—

(3019060) Gas panel - Arterial blood

741

4230

1.84

48.20

4.2

4.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3675

30280

1.43

47.70

2.6

2.4

—

(3049717) Cytology report of Urine Cyto stain

427

2023

2.18

47.20

2.8

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

804

4758

1.78

46.30

1.7

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6221

56969

1.64

46.15

7.6

6.4

mmol/mol

40.9

40.6

1.58

5799

52260

(3009542) Hematocrit [Volume Fraction] of Blood

5706

51243

1.53

45.99

24.4

14.9

38.7

39.5

7.95

3745

33453

(3007461) Platelets [#/volume] in Blood

6864

64709

2.09

45.80

35.0

19.8

e9/l

247.2

244.2

3.06

6757

62646

(3010813) Leukocytes [#/volume] in Blood

6866

64744

2.09

45.63

35.0

19.9

e9/l

7.0

6.7

12.46

6747

62421

(3024731) MCV [Entitic volume]

6864

64729

2.08

45.44

34.9

19.8

91.5

0.06

6805

63514

(3026361) Erythrocytes [#/volume] in Blood

6864

64736

2.08

45.31

35.0

19.8

e12/l

4.4

4.5

41.35

6742

62416

(3035941) MCH [Entitic mass]

6863

64726

2.08

45.26

34.8

19.8

30.3

30.4

6.26

6804

63512

(3000963) Hemoglobin [Mass/volume] in Blood

6864

64745

2.08

45.15

35.3

20.0

g/l

132.2

136.2

84.36

6805

63548

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

361

1630

2.28

44.85

1.4

1.2

—

(3019225) pH of Specimen

984

6216

1.67

44.64

5.0

3.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

80.62

42.88

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

779

4669

1.75

42.75

2.5

1.8

nmol/l

365.7

366.7

0.04

720

4201

(3003327) Ova and parasites identified in Stool by Light microscopy

358

1646

2.24

42.57

1.7

—

(36660697) Celiac disease serology panel - Serum

715

4199

1.78

42.08

1.2

—

(3044889) 12 lead EKG panel

4882

42864

1.42

41.19

5.0

4.0

—

(3000494) Fungus identified in Specimen by Culture

1038

6781

1.62

40.98

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

394

1913

2.12

40.83

3.2

2.5

g/l

0.4

0.3

0.40

178

669

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

555

3056

1.88

40.22

10.6

9.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2745

21911

1.41

40.21

4.3

4.0

mg/mmol

10.2

8.8

0.78

1843

13723

(3009508) Creatinine [Moles/volume] in Urine

2664

21162

1.41

40.10

3.5

3.2

mmol/l

7.5

7.4

0.36

2247

17595

(3043409) Potassium [Moles/volume] in Arterial blood

395

1934

2.10

40.04

4.4

mmol/l

3.8

3.9

2.38

387

1825

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

7.99

40.02

1.3

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

2468

1.98

39.92

2.3

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

2471

1.97

39.78

2.3

1.4

g/l

7.5

0.16

348

1801

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

471

2465

1.97

39.73

2.3

1.4

g/l

3.9

3.8

0.09

333

1733

(3012516) Albumin [Mass/volume] in Urine

2611

20739

1.40

39.03

3.6

3.2

mg/l

383.5

290.3

0.51

1760

13050

(3020961) Endomysium IgA Ab [Titer] in Serum

451

2343

1.99

38.84

1.1

titre

135.8

207.0

—

(40768795) Lymph node Pathology biopsy report

121

5.83

38.70

1.1

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

350

1658

2.17

38.63

2.8

1.5

u/ml

55.5

27.6

0.95

334

1574

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

387

1909

2.08

38.45

2.5

2.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

465

2451

1.96

38.40

4.7

3.7

mmol/l

24.7

24.9

1.30

438

2227

(3022313) Gas panel - Capillary blood

518

2839

1.89

38.04

4.6

3.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

635

3714

1.78

37.75

2.6

2.3

g/l

10.6

10.9

0.62

591

3368

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

437

2268

1.99

37.73

2.5

2.3

ug/l

413.5

711.1

1.50

413

2136

(3021589) Normoblasts [#/volume] in Blood

3050

24998

1.38

37.23

11.6

8.7

e9/l

0.0

0.31

2473

20417

(46235355) HIV 1 and 2 tests - Meaningful Use set

872

5581

1.64

37.15

1.7

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

663

3948

1.75

37.01

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

535

2992

1.85

36.85

3.2

2.7

0.7

0.13

510

2860

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

403

2050

2.02

36.81

2.4

1.5

g/l

1.0

0.5

1.52

352

1727

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

440

2310

1.96

36.74

2.3

1.4

g/l

10.2

10.3

0.27

374

1907

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

2307

1.96

36.55

2.3

1.4

g/l

3.1

3.0

1.05

344

1770

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

461

2491

1.91

35.31

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

524

2951

1.84

35.26

1.9

1.5

g/l

1.4

1.2

0.63

485

2646

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

18.73

35.22

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

399

2068

1.98

34.55

1.7

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6330

59012

1.56

34.51

6.0

5.0

mmol/l

6.1

5.60

5861

53307

(3000492) Spirometry study

804

5154

1.63

33.86

1.7

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

200

787

2.58

33.67

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1676

12574

1.43

33.59

4.5

4.0

ng/l

504.9

568.3

0.25

1401

10385

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

360

1817

2.03

33.58

2.4

1.5

g/l

0.0

0.21

330

1635

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

788

2.58

33.58

6.1

5.3

iu/ml

858.8

976.7

0.08

117

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6475

60748

1.60

33.56

6.1

5.4

mmol/l

2.6

2.7

7.98

6016

55566

(3037522) Nuclear Ab [Titer] in Serum

1109

7674

1.53

33.49

1.4

1.3

titre

415.9

537.4

2.16

242

1685

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

429

2321

1.90

32.71

2.0

1.9

ug/l

1.9

1.8

0.15

386

2015

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6136

56985

1.49

32.35

4.8

4.3

mmol/l

1.4

1.3

11.64

5616

51502

(3003694) ABO and Rh group [Type] in Blood

1765

13473

1.41

31.81

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

646

3985

1.68

31.52

4.5

3.4

kpa

5.1

5.2

0.92

603

3653

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

336

1700

2.02

31.13

2.4

1.5

g/l

0.0

0.50

306

1522

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

331

1666

2.03

31.11

2.4

1.5

g/l

0.0

0.00

306

1515

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

205

4.13

31.05

3.4

1.2

nmol/l

185.1

82.6

1.21

200

(3008152) Bicarbonate [Moles/volume] in Arterial blood

647

4014

1.67

30.87

7.1

6.9

mmol/l

24.6

0.03

612

3729

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2720

22356

1.35

30.70

5.2

4.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

279

1325

2.15

30.59

2.8

2.4

g/l

3.7

3.6

1.10

266

1248

(3017446) Testosterone [Moles/volume] in Serum or Plasma

583

3533

1.71

30.37

2.4

2.2

nmol/l

12.1

14.5

10.05

507

3078

(3009343) pH of Capillary blood

633

3923

1.67

30.31

4.5

3.4

7.4

2.11

489

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

366

1935

1.94

29.89

2.3

1.4

g/l

37.5

37.7

0.13

318

1612

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

613

3786

1.68

29.72

4.5

3.4

mmol/l

1.2

1.9

4.45

481

2784

(3034860) Kappa light chains.free [Mass/volume] in Serum

375

2008

1.91

29.48

3.0

1.6

mg/l

55.3

47.0

1.25

331

1605

(3021879) Hepatitis B virus core Ab [Presence] in Serum

473

2725

1.79

29.43

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

251

1163

2.20

29.29

1.7

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

373

2004

1.91

29.02

3.0

1.6

mg/l

41.0

37.0

0.46

329

1597

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6283

58891

1.49

29.01

5.3

4.8

mmol/l

1.4

1.5

7.39

5821

53715

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

364

1949

1.91

28.62

3.0

1.6

ratio

1.3

2.1

1.15

160

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6321

59367

1.50

28.41

5.4

4.8

mmol/l

4.5

4.6

8.00

5880

54536

(3004119) Hemoglobin [Mass/volume] in Venous blood

634

3995

1.64

28.40

3.7

3.4

g/l

124.3

130.5

8.49

623

3889

(3052851) Hemolysis interference index of Serum or Plasma

334

1743

1.96

28.33

4.2

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

2013

15958

1.36

28.20

5.6

4.1

estimate

0.0

1.98

443

4867

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

260

1243

2.13

28.04

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

848

5742

1.54

27.96

1.9

1.7

1.6

1.5

2.93

714

4910

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

403

3.04

27.94

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

403

3.04

27.94

1.6

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

403

3.04

27.94

1.6

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

126

438

2.91

26.99

1.9

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

279

1391

2.05

26.92

2.4

2.1

90.4

89.9

0.14

261

1301

(21494890) Protein electrophoresis panel - 24 hour Urine

151

583

2.62

26.49

1.7

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

186

794

2.38

26.36

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

132

478

2.79

26.23

1.9

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.43

25.84

4.6

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

227

1065

2.17

25.71

1.5

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

324

1733

1.91

25.55

1.7

1.4

iu/ml

10.9

20.4

—

(40768806) Pleura Pathology biopsy report

128

463

2.80

25.50

1.7

1.6

—

(3003338) MCHC [Mass/volume]

5266

48238

1.33

25.04

31.5

17.8

g/l

330.6

332.3

32.72

5229

47858

(3028308) Erythrocytes [#/volume] in Pleural fluid

140

537

2.64

24.91

1.6

1.5

e6/l

66179.1

60988.4

0.06

314

(3009445) Proteinase 3 Ab [Units/volume] in Serum

459

2755

1.71

24.68

1.6

1.5

u/ml

13.1

16.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1510

11689

1.37

23.96

5.1

4.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

377

2160

1.79

23.87

1.6

titre

146.0

340.5

—

109

(3023199) Leukocytes [#/volume] in Pleural fluid

149

603

2.50

23.76

1.6

1.5

e6/l

2160.9

2585.4

0.26

103

445

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

390

2262

1.77

23.68

1.9

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

163

691

2.39

23.50

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

163

691

2.39

23.50

1.6

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

159

667

2.41

23.47

1.6

1.5

g/l

34.1

28.9

5.64

143

582

(3037756) Immunofixation for Serum or Plasma

242

1206

2.04

23.41

1.5

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

163

694

2.38

23.28

1.6

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

702

2.37

23.15

1.6

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2817

23914

1.29

23.15

5.6

3.9

ug/l

2.8

2.3

0.75

2557

21429

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

146

593

2.49

23.12

3.0

2.4

u/ml

685.0

14863.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

414

2467

1.72

22.84

2.1

1.8

—

(40768443) Skin Pathology biopsy report

410

2440

1.72

22.73

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

177

3.81

22.31

3.3

1.1

u/ml

20.7

134.1

1.45

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

246

1258

1.99

22.16

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

162

704

2.33

22.11

1.6

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

165

724

2.31

22.02

1.6

1.3

—

(3045142) Bone marrow Pathology biopsy report

110

400

2.78

21.76

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

275

1477

1.90

21.44

1.2

titre

121.5

157.5

0.26

134

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

239

1225

1.98

21.40

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

239

1225

1.98

21.40

1.5

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

275

1483

1.89

21.18

1.2

titre

1223.3

1067.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

190

898

2.15

21.18

1.4

1.3

u/l

10.5

9.6

0.37

149

715

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

246

1288

1.94

20.72

2.6

2.4

197.5

191.6

0.49

234

1217

(3036489) Thrombin time

327

1878

1.78

20.55

2.2

1.9

22.0

21.5

0.67

294

1641

(3000093) Morphology [Interpretation] in Blood Narrative

128

519

2.49

20.39

1.1

—

(3012441) Differential panel - Pleural fluid

126

509

2.50

20.23

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1237

9501

1.36

20.23

1.3

u/ml

11.5

14.9

0.88

455

3503

(3027273) Bicarbonate [Moles/volume] in Venous blood

501

3248

1.58

19.82

4.4

3.3

mmol/l

24.9

25.2

1.10

493

3144

(40760888) Immunoglobulin light chains.free panel - Serum

268

1471

1.85

19.55

2.9

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1112

1.98

19.47

1.7

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

176

837

2.13

19.34

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

129

540

2.41

19.21

2.2

2.0

—

0.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

223

1161

1.95

19.12

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

227

1189

1.94

19.12

3.9

2.5

umol/l

35.9

33.2

0.67

202

1015

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

18.75

1.0

0.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

116

468

2.50

18.71

1.5

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

159

739

2.18

18.54

6.8

6.7

mg/l

12.3

12.0

0.22

150

663

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

112

447

2.53

18.48

1.5

1.3

u/l

293.9

306.1

0.11

106

420

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1283

10044

1.34

18.32

1.3

iu/ml

29.7

37.6

1.35

369

3133

(3004809) Band form neutrophils/100 leukocytes in Blood

153

713

2.17

17.74

3.4

2.8

1.4

1.2

0.27

115

540

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2268

19205

1.26

17.68

5.1

3.8

22.1

24.2

8.97

1219

9398

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

128

555

2.33

17.64

1.3

1.2

u/l

55.3

58.3

0.18

347

(3051651) Icteric interference index of Serum or Plasma

286

2.89

17.60

4.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

219

1167

1.90

17.55

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

157

743

2.14

17.51

1.1

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

107

431

2.50

17.35

1.4

mmol/l

6.7

6.8

0.09

387

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1067

8188

1.36

17.31

4.8

4.9

32.6

32.8

0.24

769

5441

(3045788) Cell count panel - Pleural fluid

112

463

2.44

17.18

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1635

13346

1.29

17.07

3.4

2.8

ug/l

0.7

0.27

1249

9163

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

228

3.09

16.95

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

228

3.09

16.95

1.5

1.4

—

(40768441) Liver Pathology biopsy report

239

3.03

16.88

1.6

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

396

2.55

16.81

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

307

2.76

16.56

1.3

1.2

u/l

83.3

85.4

0.08

258

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

166

3.45

16.54

2.8

2.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

181

3.33

16.48

34.7

34.0

ug/l

7.1

7.4

0.47

168

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

164

809

2.05

16.42

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

128

573

2.26

16.41

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

355

2.61

16.32

2.5

2.0

umol/l

13.7

15.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

165

819

2.04

16.25

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

150

719

2.11

16.22

1.6

1.5

u/ml

108.3

120.3

0.59

150

(3051611) Lipemic interference index of Serum or Plasma

133

609

2.21

16.15

4.1

3.4

—

(4281824)

290

2.78

16.03

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

756

2.07

16.01

1.5

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

517

2.30

15.92

3.7

3.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

281

1664

1.72

15.90

1.5

g/l

1.2

0.02

268

1566

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

130

597

2.20

15.68

3.8

3.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

805

6003

1.38

15.54

3.0

ng/l

221.6

221.1

0.01

733

5508

(21494434) Karyotype in Bone marrow

103

432

2.40

15.36

1.1

—

(3024928) Oxygen saturation in Venous blood

233

1322

1.79

15.33

2.5

3.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

273

1621

1.71

15.31

1.5

g/l

0.2

0.35

262

1531

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

298

2.70

15.24

1.3

1.2

u/l

21.7

19.5

0.27

246

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

319

2.62

14.88

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

369

2.48

14.62

1.5

1.3

u/l

28.3

33.5

0.76

259

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

164

846

1.96

14.54

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

900

6901

1.35

14.52

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

329

2.57

14.51

2.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

116

526

2.22

14.47

3.6

2.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

338

2152

1.60

14.45

1.1

u/ml

1.0

8.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

452

3084

1.50

14.14

3.1

3.0

pmol/l

4.3

4.4

1.00

405

2682

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

365

2388

1.56

13.89

1.5

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

240

2.81

13.78

2.3

2.0

e6/l

617.7

725.4

0.56

107

(44790048)

117

544

2.17

13.74

1.6

1.4

—

(44790047)

117

544

2.17

13.74

1.6

1.4

—

(44806118)

117

544

2.17

13.74

1.6

1.4

—

(44790049)

117

544

2.17

13.74

1.6

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

195

2.99

13.38

31.7

25.9

ug/l

114.5

113.4

0.05

159

(3002385) Erythrocyte distribution width [Ratio]

5026

47038

1.22

13.34

27.9

16.1

14.1

13.7

56.67

4941

45833

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

288

2.59

12.99

1.7

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

275

1710

1.63

12.98

1.5

1.6

iu/ml

0.1

2.0

0.61

382

(3006462) Nitrate [Presence] in Urine

289

2.58

12.90

5.0

3.4

—

(3042733) HLA Ab [Presence] in Serum

153

3.22

12.82

5.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

106

488

2.19

12.79

3.6

2.7

60.0

60.8

0.11

321

(3024891) Influenza virus A+B Ag [Presence] in Specimen

213

1246

1.73

12.67

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

327

2142

1.55

12.40

1.5

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

446

3133

1.45

12.05

3.0

2.6

e6/l

0.4

0.3

0.46

435

3066

(1761868) Lipid panel - Serum or Plasma

1613

18924

0.81

12.03

3.1

3.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

146

775

1.90

11.97

1.2

—

(3036603) Volume of Urine

361

2.34

11.96

1.6

1.4

1755.3

2036.7

0.80

(3016650) Hepatitis A virus Ab [Presence] in Serum

139

727

1.93

11.92

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

254

1587

1.62

11.79

1.8

1.7

—

(4211845)

321

2.41

11.74

4.9

3.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

151

818

1.86

11.64

2.6

2.2

mg/l

29.2

25.5

0.30

208

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

136

712

1.93

11.64

1.1

g/l

1.5

0.33

124

617

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

679

1.95

11.55

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

137

721

1.92

11.54

1.2

—

(3024932) HLA-DR beta [Type]

134

3.22

11.32

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

341

2.33

11.17

1.7

—

(3024471) HLA-A [Type]

137

3.15

10.93

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

515

2.05

10.83

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

123

3.26

10.77

1.1

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

204

2.71

10.68

2.1

1.9

e9/l

0.3

0.2

1.43

181

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

135

727

1.87

10.64

1.3

1.2

u/ml

296.1

295.9

0.00

457

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

216

2.65

10.63

2.1

1.9

e6/l

625.1

437.7

0.60

184

(3048929) Epstein Barr virus Ab [Presence] in Serum

179

1051

1.72

10.58

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

234

1478

1.60

10.44

3.4

3.1

nmol/l

0.8

0.73

180

1151

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

476

3474

1.40

10.41

1.3

au/ml

72.2

48.5

0.89

152

(3045414) Leukocytes [Presence] in Urine

391

2761

1.44

10.30

2.0

1.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

919

1.76

10.23

1.5

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

154

2.93

10.15

2.2

2.7

e6/l

557.9

617.1

0.10

109

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

132

717

1.86

10.15

1.2

u/ml

3.0

4.5

1.35

320

(3017732) Neutrophils [#/volume] in Blood

529

3950

1.37

10.06

2.8

3.0

e9/l

4.1

0.08

396

2847

(3000060) B lymphocytes [#/volume] in Blood

4.32

10.03

1.7

1.9

e6/l

1302.9

140.9

0.47

(40762365) Oxygen content in Arterial blood by calculation

3.76

10.01

2.3

2.7

ml/dl

14.4

15.4

0.79

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

320

2.29

10.00

1.2

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

271

2.41

9.97

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

134

737

1.83

9.91

1.2

u/ml

1.6

4.1

1.60

237

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

343

2384

1.46

9.84

2.0

1.8

u/l

38.5

38.7

0.09

297

2042

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

514

3836

1.37

9.81

2.5

2.4

au/ml

21.1

25.6

0.30

152

(3000475) Leukocytes [#/volume] in Synovial fluid

260

1711

1.54

9.73

1.7

1.5

e6/l

16115.0

13923.9

0.24

185

1230

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.83

9.72

1.7

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

214

1348

1.61

9.68

3.4

2.6

mg/l

1.8

1.7

0.40

201

1185

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

113

593

1.92

9.68

1.1

—

(3048879) Bone marrow aspiration report

132

3.04

9.63

1.7

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

345

2.22

9.60

1.5

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

122

3.13

9.58

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

258

2.42

9.57

1.5

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

258

2.42

9.57

1.5

1.2

—

(3011412) CD3 cells [#/volume] in Blood

302

2.30

9.51

2.1

2.0

e9/l

1.2

1.0

0.73

168

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

133

3.02

9.51

2.0

2.4

e6/l

2558.1

26860.9

0.89

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

347

2.20

9.48

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

690

1.84

9.47

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

360

2.18

9.47

1.5

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

408

2.10

9.35

1.1

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

265

1767

1.52

9.35

2.4

2.3

ug/min

138.0

118.4

0.28

145

1041

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

212

1347

1.59

9.27

1.1

u/ml

1.7

10.6

3.73

126

(44816559) Phosphatidylethanol [Mass/volume] in Blood

157

924

1.71

9.25

1.5

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

125

3.05

9.21

1.1

—

(40765096) Chromosome analysis panel by Banding

3.81

9.21

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

442

3257

1.38

9.14

1.3

u/ml

308.0

231.2

0.30

406

3008

(3035880) pH of Pleural fluid

270

2.34

9.13

1.4

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

259

2.37

9.03

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

462

2.00

8.98

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

230

1503

1.55

8.92

1.7

1.8

nmol/l

41.8

43.5

0.49

221

1432

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

459

1.99

8.78

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

166

1007

1.66

8.77

1.6

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

353

2.14

8.71

1.5

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

2.73

8.58

2.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

2.73

8.58

2.0

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

164

2.69

8.54

1.5

1.4

52.7

63.5

1.05

134

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

160

2.70

8.38

2.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

759

6112

1.27

8.37

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.47

8.35

12.8

11.4

mmol/l

4.9

5.1

0.13

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.82

8.22

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

277

2.25

8.20

2.0

2.2

36.2

44.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

466

1.94

8.09

2.3

1.7

u/l

578.4

1967.2

1.33

181

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

135

795

1.71

8.00

1.5

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

221

1469

1.52

7.97

2.3

1.9

mg/l

13.6

11.4

3.54

209

1351

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

160

2.63

7.84

2.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

714

1.74

7.69

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

271

1892

1.45

7.67

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

222

2.35

7.66

1.8

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

222

2.35

7.66

1.8

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

222

2.35

7.66

1.8

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

434

1.95

7.63

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

223

2.34

7.59

1.9

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

173

1106

1.58

7.45

1.8

1.9

pmol/l

178.3

199.9

2.36

157

1040

(3024980) IgG subclass 4 [Mass/volume] in Serum

142

866

1.65

7.41

1.5

1.6

g/l

0.7

0.9

0.66

107

656

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

232

2.29

7.39

1.2

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

577

4565

1.29

7.34

4.1

3.7

0.8

0.34

201

1003

(3002331) Protein [Mass/volume] in Peritoneal fluid

104

2.99

7.33

1.7

1.5

g/l

29.3

82.9

0.45

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

125

740

1.70

7.31

1.3

1.4

pmol/l

156.2

77.0

1.17

119

720

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

189

1239

1.54

7.30

1.1

—

(3003181) Sodium [Moles/volume] in Urine

171

1096

1.57

7.30

1.5

1.3

mmol/l

61.8

63.8

0.23

129

881

(40758358) Immune stain study

+∞

7.29

1.0

0.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

136

825

1.66

7.26

1.5

1.2

nmol/l

0.2

0.3

0.99

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

719

1.71

7.25

1.5

1.3

nmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

121

2.82

7.24

1.3

ug/l

170.7

68.5

0.44

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

203

2.37

7.24

1.8

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

138

2.69

7.23

1.9

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

306

2209

1.40

7.22

1.2

u/ml

0.2

0.9

3.01

207

(3033799) Differential panel - Peritoneal fluid

133

2.72

7.16

2.0

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

126

753

1.69

7.12

1.5

1.2

—

(3047189) Immunofixation for 24 hour Urine

231

2.26

7.03

1.6

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.30

6.95

3.3

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

274

1956

1.42

6.91

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

325

2.04

6.89

1.8

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

221

2.27

6.85

1.9

2.0

14.7

16.4

0.34

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

102

584

1.76

6.75

1.1

u/ml

3.3

3.6

0.09

225

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

321

2.03

6.75

1.4

1.3

nmol/l

0.3

0.2

0.41

240

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

179

2.41

6.74

3.3

2.6

41.6

41.9

—

(3044941) Cell count panel - Synovial fluid

166

1079

1.55

6.70

1.5

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

316

2.03

6.65

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

468

1.83

6.42

1.2

titre

57.5

164.2

—

(4268621)

499

1.79

6.34

2.2

2.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.01

6.22

1.5

1.0

ug/l

1.9

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

126

2.63

6.20

1.5

1.8

g/l

15.3

13.5

0.48

(1002224) Polysomnography panel

268

1946

1.39

6.16

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.96

6.16

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

180

1217

1.49

6.08

1.2

u/ml

1.4

6.9

—

101

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

189

1292

1.48

6.05

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1606

14305

1.16

6.02

1.7

pmol/l

41429004.3

30940318.6

0.27

1330

11629

(3032057) Clostridioides difficile [Presence] in Stool

134

2.54

6.01

1.9

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

127

798

1.60

5.97

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

142

2.47

5.84

1.4

2.1

u/ml

76682.0

75614.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

675

1.64

5.71

1.4

1.3

e6/l

208039.5

187451.0

0.08

461

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

984

1.52

5.66

1.7

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

112

693

1.63

5.63

1.2

117.3

116.1

0.13

105

622

(3020393) Adenovirus Ag [Presence] in Stool

4.06

5.62

1.4

1.0

—

(3042631) Mycobacterium sp identified in Specimen

121

764

1.59

5.60

2.6

3.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

958

1.52

5.51

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

183

1270

1.45

5.46

1.6

1.7

iu/l

7.5

4.7

0.95

421

(3008295) Osmolality of Serum or Plasma

546

1.69

5.44

1.5

1.4

mosm/kgh2o

280.4

277.3

0.49

416

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

219

1572

1.41

5.43

1.2

u/ml

12.1

42.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

479

1.74

5.43

1.3

1.2

u/ml

2.2

4.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

146

971

1.51

5.39

1.7

1.8

mu/l

245.7

309.9

3.18

129

891

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

293

1.95

5.37

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

294

1.95

5.32

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

152

1023

1.50

5.31

1.2

u/l

33.5

25.8

0.66

137

873

(3024263) Appearance of Synovial fluid

351

1.86

5.30

1.4

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

330

1.89

5.28

1.7

1.4

u/l

4.9

7.5

0.56

139

(4306422)

114

723

1.59

5.21

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

115

731

1.58

5.21

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.05

5.21

5.2

4.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

114

2.55

5.19

2.4

2.0

—

(1616796) Gas panel - Central venous blood

186

1311

1.43

5.13

5.0

3.7

—

(3051593) INR in Capillary blood by Coagulation assay

348

1.85

5.12

10.7

10.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

511

1.69

5.09

1.2

u/ml

19.6

41.2

—

(40768446) Kidney Pathology biopsy report

197

2.14

5.08

1.9

1.6

—

(3044007) Cell count panel - Peritoneal fluid

123

2.44

4.94

2.0

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.04

4.93

1.6

2.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

204

1473

1.40

4.93

1.2

1.3

u/ml

8.4

5.3

0.29

246

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

707

5987

1.20

4.87

3.7

3.3

—

(3006270) Folate [Moles/volume] in Blood

572

1.63

4.85

1.3

1.2

nmol/l

297.4

343.0

1.48

458

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

129

861

1.51

4.73

1.4

1.2

miu/ml

212.5

208.4

0.04

351

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.95

4.70

1.6

2.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

240

1796

1.35

4.67

1.5

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

524

1.65

4.67

1.2

u/ml

45.7

50.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

120

792

1.52

4.65

1.5

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

549

1.63

4.61

1.6

1.7

u/ml

18.6

24.4

1.37

123

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

212

2.03

4.60

1.9

2.3

—

(3020491) Glucose [Moles/volume] in Blood

436

1.70

4.56

1.5

2.1

mmol/l

6.8

7.0

0.22

292

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

311

1.84

4.55

2.2

2.4

—

(3021788) Differential panel - Synovial fluid

176

1261

1.41

4.49

1.6

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

529

4395

1.22

4.45

4.2

3.8

0.1

0.04

173

936

(3037692) Legionella sp identified in Specimen by Organism specific culture

168

2.15

4.45

1.3

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.00

4.43

1.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

180

1299

1.40

4.41

5.8

4.1

kpa

5.1

5.0

0.72

172

1262

(3027315) Oxygen [Partial pressure] in Blood

181

1310

1.39

4.36

5.8

4.2

kpa

8.3

8.4

0.29

173

1272

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

198

1456

1.37

4.33

1.2

u/ml

1.9

6.7

1.16

162

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.50

4.32

1.4

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.88

4.32

1.3

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

8.90

4.27

1.5

1.2

—

(3012501) Base excess in Blood by calculation

179

1298

1.39

4.27

5.8

4.1

mmol/l

3.0

2.6

1.38

126

876

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

126

2.31

4.25

1.7

1.4

16.0

26.1

1.28

103

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.70

4.24

1.2

1.3

nmol/l

5.4

380008.6

0.72

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

139

2.24

4.23

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.04

4.23

1.9

2.3

—

(3010421) pH of Blood

206

1531

1.36

4.23

5.5

4.1

7.4

0.51

171

1263

(4024509)

641

1.55

4.22

1.8

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.80

4.11

1.4

1.5

14.9

8.5

0.42

(4062490)

566

1.58

4.11

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

141

2.20

4.10

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

141

2.20

4.10

1.2

pmol/l

247.9

269.4

0.20

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

535

1.60

4.10

1.2

96.1

94.6

0.22

505

(3023323) Follitropin [Units/volume] in Serum or Plasma

155

1107

1.41

4.06

1.3

iu/l

34.8

34.2

0.07

128

962

(3024139) IgG subclass 3 [Mass/volume] in Serum

568

1.57

4.05

1.4

g/l

0.4

0.15

405

(3028192) IgG subclass 2 [Mass/volume] in Serum

568

1.57

4.05

1.4

g/l

2.6

3.0

1.41

400

(3027135) IgG subclass 1 [Mass/volume] in Serum

568

1.57

4.05

1.4

g/l

6.6

6.8

0.33

402

(3004616) Nuclear Ab [Presence] in Serum

115

779

1.48

3.99

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1383

0.65

3.99

4.3

3.5

mg/l

33.0

26.5

0.75

903

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

213

1.93

3.85

13.4

11.3

mmol/l

0.6

0.7

0.64

196

(4094501)

235

1808

1.31

3.84

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.97

3.84

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.68

3.81

1.6

1.7

umol/l

54.2

43.6

0.50

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

316

1.75

3.77

1.9

2.1

u/field

4.0

1.8

0.69

206

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.40

3.71

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.57

3.71

3.6

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

267

1.80

3.67

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

741

6457

1.16

3.67

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

2.12

3.63

1.2

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

211

1.90

3.61

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

247

1.83

3.60

9.6

5.5

mg/l

65.6

67.8

0.09

168

(3023419) Bacteria identified in Sputum by Culture

116

808

1.44

3.54

2.6

2.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.05

3.52

1.1

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

3.85

3.52

1.1

1.2

—

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

565

1.53

3.50

1.0

1.1

u/ml

1.0

0.7

0.28

219

(3015235) Bicarbonate [Moles/volume] in Capillary blood

213

1640

1.31

3.50

3.5

3.0

mmol/l

24.5

24.9

0.61

183

1441

(44813793)

354

1.67

3.49

1.1

—

(3028433) Virus identified in Specimen by Culture

179

1.96

3.47

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.47

3.45

2.0

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

536

1.54

3.42

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

266

1.77

3.42

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

162

1207

1.35

3.35

1.4

1.2

mmol/l

3.8

3.9

0.39

151

1128

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.25

3.34

1.2

nmol/l

0.3

0.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

494

4204

1.19

3.29

4.1

3.6

0.6

0.04

146

754

(3003888) Timothy IgE Ab [Units/volume] in Serum

582

1.50

3.28

1.0

1.1

u/ml

2.4

3.0

0.23

263

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

463

1.56

3.25

1.3

titre

68.9

67.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

535

1.52

3.25

1.7

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

170

1.95

3.22

1.2

g/l

0.3

0.08

135

(3000330) Specific gravity of Urine by Test strip

399

3342

1.21

3.17

4.2

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

221

1735

1.28

3.17

4.7

4.1

—

(3025159) Blasts/100 leukocytes in Blood

490

4182

1.18

3.17

4.2

3.8

0.1

0.3

0.68

154

817

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

193

1.87

3.14

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.25

3.12

1.1

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

1414

1.31

3.11

2.5

2.2

g/l

124.5

131.0

2.31

108

1036

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

290

1.69

3.09

1.3

1.1

u/l

28.0

24.8

0.11

212

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

180

1382

1.31

3.07

1.4

1.3

mg/l

506.3

544.4

0.46

164

1300

(3016750) Collection duration of Urine

391

1.59

3.06

2.5

2.1

min

487.4

503.9

0.76

301

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

291

1.69

3.05

1.3

1.1

u/l

89.2

83.7

0.20

222

(3006653) Thiamine [Moles/volume] in Blood

292

1.68

3.02

1.1

1.2

nmol/l

145.4

138.5

0.39

292

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.00

2.97

1.2

1.1

iu/ml

6.6

8.2

—

(3025130) Human papilloma virus identified in Specimen

450

1.54

2.96

1.5

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

483

1.52

2.94

1.3

titre

48.3

458.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.15

2.92

1.0

1.3

—

(3023410) Appearance of Cerebral spinal fluid

485

1.51

2.89

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

102

2.16

2.86

1.7

1.1

ug/l

27.0

2.6

0.53

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

282

1.67

2.84

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

677

1.42

2.82

1.1

u/ml

2.1

1.2

0.27

271

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

392

1.56

2.81

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

392

1.56

2.81

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.45

2.79

1.1

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

158

1.90

2.79

1.2

110.8

114.4

0.25

135

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

137

1.97

2.79

1.6

1.8

mg/l

8.5

9.4

0.39

109

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

393

1.56

2.78

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

387

1.55

2.73

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

395

1.55

2.73

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

388

1.55

2.70

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

388

1.55

2.70

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

280

1.65

2.66

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.39

2.62

1.1

—

(3022621) pH of Urine by Test strip

476

4123

1.17

2.62

3.5

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

1047

1.32

2.61

1.3

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

4.67

2.59

1.9

1.5

ng/l

192.4

199.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

370

1.54

2.55

1.3

1.5

umol/l

14.2

13.7

0.17

347

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

369

3138

1.19

2.55

1.2

iu/ml

111.9

132.4

0.47

135

1172

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

500

1.46

2.53

1.9

2.2

u/field

3.4

1.9

0.56

184

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.87

2.50

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

136

1.91

2.49

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

721

1.38

2.46

2.9

1.6

31.4

32.8

2.17

715

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.55

2.44

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

203

1.73

2.43

1.1

miu/ml

1395.4

1655.5

0.73

203

(3018133) Calcium [Moles/volume] in Urine

2.29

2.40

1.2

1.6

mmol/l

2.6

2.7

0.08

(3016038) Potassium [Moles/volume] in Urine

416

1.49

2.40

1.3

1.1

mmol/l

33.7

34.6

0.10

344

(21494755) Public health laboratory ask at order entry panel

287

3413

0.83

2.38

1.3

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

426

1.48

2.36

1.0

1.1

mg/l

276.3

285.5

0.60

378

(3034274) Bile acid [Moles/volume] in Serum --fasting

259

1.63

2.34

1.6

umol/l

6.5

8.4

0.52

179

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

1.60

2.33

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.69

2.27

1.2

g/l

19.6

14.8

1.22

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.22

2.27

2.0

1.7

umol/l

12.7

18.0

1.77

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.22

2.27

1.6

1.3

mmol/l

0.4

2.1

0.91

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.48

2.26

1.1

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.56

2.26

1.0

1.1

u/l

3.6

14.5

1.21

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

262

1.61

2.25

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

149

1.82

2.23

1.4

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

343

1.52

2.21

2.1

2.2

ug/min

85.8

198.8

0.79

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

195

1.70

2.18

6.7

5.6

64.6

70.4

0.70

165

(3011648) Oxygen content in Venous blood

467

1.44

2.17

2.1

2.2

10.8

11.1

0.19

467

(4146454)

105

790

1.33

2.17

2.4

2.7

—

(3014271) Vancomycin [Susceptibility]

377

1.49

2.17

3.2

3.0

—

(3044290) Cell count panel - Cerebral spinal fluid

137

1072

1.28

2.13

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

647

1.36

2.11

3.5

3.0

mg/l

88.7

39.9

0.39

469

(40765089) Chromosome analysis panel - Blood by G-banded

2.70

2.10

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

840

1.31

2.06

3.0

2.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

2679

1.18

2.06

4.8

1.7

1.6

0.97

296

2516

(3007930) Methemoglobin/Hemoglobin.total in Blood

309

2642

1.18

2.06

4.9

4.8

0.9

0.28

292

2480

(3028626) Oxygen [Partial pressure] in Capillary blood

166

1336

1.25

2.06

3.1

2.8

kpa

7.9

0.14

151

1235

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

357

1.49

2.06

1.5

u/l

5.2

6.0

1.32

308

(3011288) Drugs identified in Urine by Screen method

490

1.41

2.04

2.9

2.3

—

(3011985) Renin [Units/volume] in Plasma

108

824

1.32

2.04

1.3

mu/l

88.5

63.7

0.60

729

(3009871) Measles virus Ab [Titer] in Serum

154

1.76

2.03

1.5

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

138

1089

1.27

2.03

1.2

u/ml

47.8

43.6

0.11

121

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

223

1.62

2.02

1.2

1.1

ng/l

649.8

481.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

2.00

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

151

1208

1.26

1.99

1.4

1.3

e6/l

29.0

23.5

0.11

114

950

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.15

1.98

2.5

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

148

1.76

1.97

1.2

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

501

0.62

1.97

4.1

3.2

13.4

13.3

0.44

496

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

151

1210

1.25

1.96

1.5

1.4

e6/l

15246.6

1170.8

0.46

117

1005

(3014051) Protein [Presence] in Urine by Test strip

174

1418

1.23

1.95

2.4

2.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

127

1.81

1.93

2.2

2.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

218

1.61

1.93

2.6

2.8

umol/l

30.2

28.5

0.47

165

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

1.86

1.91

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

111

860

1.30

1.90

5.5

4.6

umol/l

368.2

356.9

0.33

728

(3013166) Neutrophils/100 leukocytes in Synovial fluid

219

1.60

1.90

1.4

1.3

52.8

55.9

0.16

187

(3028707) Methadone [Presence] in Urine by Screen method

367

1.45

1.83

2.9

1.9

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

4.17

1.82

1.0

1.5

umol/l

79.4

229.6

—

(3004775) Volume in Urine collected for unspecified duration

571

1.35

1.80

2.6

2.3

737.1

644.5

1.24

397

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

199

1.61

1.79

1.4

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

1.79

2.2

3.0

u/field

0.3

0.6

1.37

(3028679) Herpes simplex virus Ab [Presence] in Serum

207

1.60

1.79

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.76

1.79

4.4

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

353

1.45

1.77

1.1

1.0

nmol/l

1.3

7.8

2.51

(3032773) Endomysium IgG Ab [Titer] in Serum

420

1.41

1.77

1.1

titre

—

(3008898) HLA-B27 [Presence]

179

1481

1.21

1.76

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.09

1.75

1.2

ug/l

116.1

126.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1772

16822

1.07

1.74

1.7

mmol/l

1.4

1.3

3.20

1547

13824

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

100

776

1.29

1.72

1.3

pmol/l

322.7

273.1

0.59

582

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.85

1.71

1.6

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.13

1.71

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

282

1.49

1.71

1.1

iu/ml

5.9

10.9

1.25

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.06

1.70

1.1

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

509

1.36

1.69

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

832

1.28

1.68

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.10

1.65

1.1

1.0

ug/l

97.7

80.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.80

1.65

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

303

1.45

1.60

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

209

0.48

1.57

1.6

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

191

1.57

1.56

1.2

1.0

u/ml

0.8

1.0

0.26

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

215

1.54

1.56

1.7

2.0

ug/l

50.8

51.8

0.05

208

(3041918) Cholesterol [Moles/volume] in Pleural fluid

107

1.78

1.54

1.7

1.2

mmol/l

1.7

1.4

0.56

(3002523) Influenza virus A Ag [Presence] in Specimen

510

1.34

1.52

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

177

1.58

1.51

1.1

1.0

u/ml

0.7

0.6

0.32

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.86

1.50

1.2

ng/l

48.2

151.4

—

(3019977) pH of Arterial blood

350

1.40

1.48

2.1

2.4

7.4

1.56

134

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

393

1.38

1.47

1.4

1.3

u/ml

3.1

1.2

0.67

200

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

284

1.45

1.47

1.3

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.13

1.44

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.92

1.43

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.04

1.43

1.0

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

1.60

1.43

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.97

1.43

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

121

989

1.23

1.40

3.7

3.4

59.8

58.1

0.67

121

989

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

304

1.42

1.39

1.5

1.4

—

(3034426) Prothrombin time (PT)

181

1.55

1.39

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.42

1.39

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

238

1.47

1.39

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.08

1.38

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

142

1.62

1.38

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

322

1.40

1.37

1.6

1.3

—

(3022689) Creatine [Moles/volume] in Urine

206

1.51

1.37

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

2.20

1.36

2.1

1.1

nmol/l

5.3

24.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.20

1.36

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

150

1260

1.19

1.33

3.2

2.6

15.3

16.4

2.80

681

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

149

1252

1.19

1.32

1.8

1.5

nmol/l

1.0

0.8

1.61

123

1034

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

121

1.65

1.30

1.5

1.8

—

(4015189)

217

1.48

1.30

1.9

2.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.78

1.28

9.8

4.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

552

1.29

1.28

1.2

1.1

—

2.7

—

(3014891) Appearance of Pleural fluid

1.79

1.26

1.6

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

130

1.62

1.26

1.1

1.2

umol/24h

0.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

170

1.53

1.25

1.1

1.3

nmol/l

96.3

159.5

2.06

119

(3036048) Francisella tularensis Ab [Titer] in Serum

108

1.67

1.22

1.1

1.2

—

320.0

—

(40758292) HTLV I+II Ab panel - Serum

2.16

1.21

1.5

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

280

1.39

1.20

1.1

1.2

ratio

1.1

0.05

(3052592) Norovirus Ag [Presence] in Stool

117

1.63

1.17

1.5

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.93

1.16

1.5

1.2

—

(3025315) Body weight

2.00

1.16

5.2

5.0

—

(3042517) Benzodiazepines panel - Urine

2.50

1.15

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

343

1.34

1.14

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

1.13

1.2

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.26

1.10

2.7

2.2

—

(3039000) Anion gap in Blood

157

1352

1.16

1.09

5.7

6.6

mmol/l

10.8

11.4

1.80

139

1214

(3018572) Chloride [Moles/volume] in Blood

157

1352

1.16

1.09

5.7

6.6

mmol/l

105.3

104.8

0.65

139

1214

(3023511) Choriogonadotropin [Units/volume] in Urine

226

1.42

1.09

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

755

1.22

1.09

2.2

1.7

—

(3047181) Lactate [Moles/volume] in Blood

217

1914

1.14

1.09

5.1

5.9

mmol/l

1.2

1.3

2.65

188

1698

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

194

0.57

1.08

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

194

0.57

1.08

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

215

2433

0.88

1.08

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

235

1.41

1.08

17.5

11.6

nmol/l

838.4

801.1

0.20

219

(3027008) Opiates [Presence] in Urine

756

1.22

1.08

2.2

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

193

0.57

1.07

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

193

0.57

1.07

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

205

0.58

1.06

1.7

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

677

1.23

1.05

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

660

1.23

1.04

1.2

—

(3028300) Cannabinoids [Presence] in Urine

760

1.21

1.03

2.2

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

1.45

1.03

1.7

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

1.45

1.03

1.7

2.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.06

1.02

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

411

1.29

1.02

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.73

1.02

1.0

1.1

—

(4198724)

130

1.54

1.02

2.2

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.69

1.01

1.1

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

123

1.55

0.99

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

115

1.57

0.99

1.1

—

(3021901) Oxygen saturation in Capillary blood

134

1151

1.17

0.99

3.4

2.8

—

(3005033) Fetal Nuchal fold Thickness US

160

0.56

0.97

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

0.56

0.97

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.50

0.97

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

241

1.37

0.96

1.2

1.1

u/l

1.7

1.1

0.47

105

(3017704) Immunofixation for Urine

337

1.31

0.95

1.4

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

101

1.59

0.93

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.73

0.92

1.0

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.14

0.91

6.2

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

253

1.35

0.89

1.4

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.07

0.89

4.8

2.8

—

(3016879) Cocaine [Presence] in Urine

710

1.20

0.89

2.2

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

385

1.27

0.89

2.6

2.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.79

0.87

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

768

1.19

0.86

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.82

0.85

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

238

1.35

0.85

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

247

1.34

0.85

26.0

16.7

nmol/l

1481.8

1412.9

0.25

238

(3027944) Amphetamines [Presence] in Urine

742

1.19

0.84

2.2

1.6

—

(3045716) Anion gap in Serum or Plasma

321

0.72

0.84

4.9

2.1

mmol/l

9.6

9.2

0.16

242

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

179

0.61

0.84

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

137

1.46

0.83

2.6

mmol/l

8.0

0.00

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

129

1.47

0.83

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

166

0.60

0.83

1.6

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

114

0.53

0.82

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

543

1.22

0.82

1.0

ng/l

273.4

336.3

1.20

360

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.88

0.81

1.5

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.64

0.81

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

138

1.45

0.81

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.70

0.80

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.82

0.79

1.0

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

243

1.32

0.76

1.9

2.2

umol/l

62.7

57.2

0.35

200

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

548

1.21

0.76

1.0

ng/l

680.7

726.7

0.27

349

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

235

1.32

0.75

1.7

2.1

umol/l

85.1

140.8

1.05

125

(3010726) Horse dander IgE Ab [Units/volume] in Serum

495

1.21

0.74

1.0

1.1

u/ml

2.8

1.8

0.17

109

(3010838) Calcium [Moles/time] in 24 hour Urine

315

1.27

0.74

1.6

1.7

—

6.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

523

1.21

0.74

1.4

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.84

0.73

3.7

2.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

551

1.20

0.73

1.0

ng/l

34.2

45.7

1.55

357

(40761539) Cells [Type] in Urine sediment by Light microscopy

125

1.44

0.72

1.2

—

(3017569) Oxygen content in Arterial blood

336

1.25

0.70

2.1

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

101

1.49

0.70

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

143

1.40

0.70

1.6

1.5

ng/l

107.7

116.3

0.16

143

(3051101) Glucose [Moles/volume] in Cord blood

143

0.63

0.69

4.2

6.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.64

0.68

2.6

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

586

1.18

0.65

2.3

1.6

—

(40761536) Microorganisms panel - Urine sediment

437

4640

0.94

0.65

5.2

4.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

120

1065

1.13

0.64

3.7

3.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.72

0.64

13.0

10.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

351

3751

0.93

0.63

1.8

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

261

1.27

0.62

1.1

1.0

—

(4212803)

1.60

0.61

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

244

1.27

0.61

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

426

1.20

0.59

1.2

mmol/l

11.3

11.9

0.21

119

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

408

1.20

0.59

1.2

1.4

mmol/l

2.1

2.2

0.14

381

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.54

0.59

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.54

0.59

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.54

0.59

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

272

1.25

0.59

1.7

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

273

1.25

0.57

1.7

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

150

1.33

0.55

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.46

0.54

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

441

1.18

0.53

1.4

promille

1.8

1.3

1.68

335

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.53

1.3

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.54

0.53

1.8

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

133

0.68

0.51

1.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.50

0.51

3.2

2.8

—

(44806071)

1.41

0.51

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

242

1.24

0.50

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

171

1.29

0.49

1.7

1.6

ug/l

8.2

9.2

0.55

171

(3015183) Erythrocyte sedimentation rate

189

1.27

0.49

1.5

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

316

1.20

0.49

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

872

1.11

0.46

1.1

iu/ml

142.8

1175.9

0.76

178

(3036670) Protein [Mass/volume] in Synovial fluid

236

1.23

0.46

1.2

g/l

39.1

39.9

0.10

122

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

164

1.28

0.46

1.3

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

464

4852

0.95

0.45

5.1

3.1

mmol/l

1.2

0.19

413

4077

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.43

0.45

1.0

1.1

—

(4133840)

141

0.71

0.44

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.37

0.43

1.2

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.40

0.42

1.0

1.2

umol/24h

2.1

1.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

123

1.30

0.40

1.6

2.9

—

(3020650) Glucose [Presence] in Urine

141

1.28

0.40

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.31

0.39

2.1

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

418

1.15

0.39

1.4

1.3

pmol/l

82.6

139.2

0.33

124

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

140

1507

0.93

0.37

1.6

1.7

—

(40757373) Influenza virus identified in Isolate

125

1.28

0.36

1.4

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

143

1.26

0.36

1.8

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

649

1.11

0.36

1.8

1.5

22.6

30.0

1.19

409

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

272

1.18

0.36

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

144

1.25

0.35

1.8

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

144

1.25

0.35

1.2

1.0

u/ml

0.6

0.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.36

0.34

1.2

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.33

0.33

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

109

1.28

0.33

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

304

1.15

0.31

3.4

4.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

101

1.29

0.31

1.2

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

156

1.22

0.31

2.1

1.7

219.1

193.1

0.41

146

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

131

0.76

0.30

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

526

0.89

0.30

1.9

ug/l

5.5

3.6

0.36

469

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.29

0.30

1.2

1.4

mmol/l

8.0

9.5

—

(3001729) Color of Synovial fluid

1.25

0.29

1.7

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

201

1911

1.05

0.29

1.6

1.7

—

(3025577) Chromium [Mass/volume] in Blood

514

0.89

0.29

2.0

ug/l

2.9

2.3

0.26

431

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

891

1.08

0.28

1.8

1.5

60.2

60.4

0.02

555

(3034891) Synovial lining cells/100 cells in Synovial fluid

333

0.87

0.27

1.6

1.5

1.7

4.0

1.49

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

139

0.79

0.26

1.2

1.1

70.6

85.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.30

0.26

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.28

0.24

1.5

1.2

—

(3012565) Volume of 24 hour Urine

293

1.13

0.24

2.4

2.0

1886.0

1927.5

0.09

255

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

693

0.92

0.23

1.1

1.2

mmol/l

6.4

7.7

2.89

486

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

456

1.10

0.23

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.32

0.23

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.28

0.23

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

189

0.85

0.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

189

0.85

0.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

189

0.85

0.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

189

0.85

0.22

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.22

0.22

1.2

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

353

1.11

0.21

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.16

0.21

1.0

2.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

211

1.14

0.20

1.9

1.6

188.1

159.4

0.76

195

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.22

0.19

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.15

0.19

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.13

0.17

1.0

1.1

—

(3000012) Reticulocyte production index

351

0.91

0.17

1.7

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.75

0.17

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.18

0.16

7.9

10.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

350

1.09

0.16

1.0

u/ml

0.2

—

(4034850)

226

2196

1.03

0.15

12.0

10.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

227

1.10

0.14

1.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1503

14904

1.01

0.13

4.1

3.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

0.88

0.11

2.5

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.09

0.09

1.0

1.3

—

(4027681)

242

1.07

0.09

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

1.10

0.09

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

350

1.06

0.09

1.5

1.4

nmol/l

1.5

1.2

0.67

271

(3025549) Creatine [Moles/time] in 24 hour Urine

1.11

0.09

1.2

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

177

1734

1.02

0.08

1.7

mg/l

6.3

3.7

0.94

135

1234

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

134

0.90

0.08

6.1

7.4

—

(3000285) Sodium [Moles/volume] in Blood

107

1.12

0.08

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.03

0.08

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

154

0.91

0.08

2.4

2.2

ug/l

2.6

3.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

313

1.05

0.07

1.5

1.3

g/l

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.80

0.07

1.3

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.07

0.07

2.3

2.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.05

0.07

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

364

1.04

0.06

2.5

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

193

0.93

0.06

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

193

0.93

0.06

2.3

2.5

nmol/l

102.5

142.3

1.23

168

(3040151) Glucose [Moles/volume] in Capillary blood

721

1.03

0.06

5.6

16.2

mmol/l

7.2

7.4

0.17

587

(3023430) Cat dander IgE Ab [Units/volume] in Serum

395

1.04

0.05

1.0

1.1

u/ml

3.2

3.0

—

150

(3039443) Prostate specific Ag panel - Serum or Plasma

113

1151

0.98

0.05

1.7

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.08

0.02

1.0

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

107

0.93

0.02

1.2

1.1

—

(3004451) EKG impression Narrative

318

0.97

0.01

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

292

2928

1.00

0.01

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

136

0.96

0.00

1.1

77.1

86.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

140

1393

1.01

0.00

1.5

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

177

1.02

0.00

1.7

1.3

25.9

35.2

—

110

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

102

0.98

0.00

1.1

1.2

108.1

107.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

159

1.01

0.00

6.1

7.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

435

1.01

0.00

1.0

1.1

u/ml

1.9

2.9

—

173

(44806420)

215

0.98

0.00

2.1

2.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

184

0.98

0.00

5.8

7.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.98

0.00

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.00

0.00

2.3

1.7

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

11.3

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.00

0.00

1.2

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.4

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_SIGMOID_COLON_EXALLC – Benign neoplasm: Sigmoid colon

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm: Sigmoid colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints